Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuwellis Inc (NUWE) vs GraniteShares 2x Long NVDA Daily ETF (NVDL) Price & Performance

Nuwellis IncTrade
GraniteShares 2x Long NVDA Daily ETFTrade

Price performance (Past 24H)

Key statistics

Nuwellis Inc vs GraniteShares 2x Long NVDA Daily ETF — how do they compare? Nuwellis Inc trades at $0.7 (market cap $2.20M), while GraniteShares 2x Long NVDA Daily ETF trades at $37.11 (market cap $3.56B). The key difference: GraniteShares 2x Long NVDA Daily ETF is far larger — about 1618.2× Nuwellis Inc's market cap, and GraniteShares 2x Long NVDA Daily ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and GraniteShares 2x Long NVDA Daily ETF for 15 Days on average.

NUWENVDL
Market Cap
$2.20M$3.56B
Volume
121,5449,740,643
Sector
HealthLeveraged / Inverse
52-Week High
$146.65$43.02
52-Week Low
$0.68$21.76
Typical Hold Time
26 Days15 Days
Enterprise Value
-$1.52M—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nuwellis Inc

NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.

The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.

GraniteShares 2x Long NVDA Daily ETF

NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $37.335, down 5.65% on the day. Technical indicators show a bullish overall signal with strong moving average support, though oscillators remain neutral. Recent news highlights Nvidia's continued AI leadership and earnings beats, driving leveraged ETF interest. The ETF aims to deliver 2x daily returns of Nvidia stock, with technical analysis showing support at $36 and resistance at $38-39 levels.

The outlook remains tied to Nvidia's AI dominance and earnings performance. Investment opportunity exists through leveraged exposure to Nvidia's growth trajectory, though risks include daily reset leverage decay and Nvidia's high valuation. Recent SpaceX earnings have reshuffled AI chip trades, creating volatility. The ETF's performance depends on Nvidia maintaining its AI market leadership and execution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NUWE
40% Buy60% Sell
Avg holding period · 26 Days
NVDL
100% Buy0% Sell
Avg holding period · 15 Days

Top news

Latest headlines on both assets

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE →

About GraniteShares 2x Long NVDA Daily ETF

NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.

Read more on NVDL →